Greenwich LifeSciences (GLSI) Earnings Date & Reports

Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GLSI is expected to report earnings to rise 9.52% to -23 cents per share on August 14

Greenwich LifeSciences GLSI Stock Earnings Reports

Q2'23

Est.

$-0.23

Q4'24

Est.

$-0.21

Q2'24

Est.

$-0.20

Q1'24

Beat

by $0.01

Q4'23

Est.

$-0.20

The last earnings report on February 26 showed earnings per share of -20 cents, meeting the estimate of -20 cents. With 22.03K shares outstanding, the current market capitalization sits at 160.63M.

View a ticker or compare two or three

Compare

GLSI